Searchable abstracts of presentations at key conferences in endocrinology

ea0013p306 | Thyroid | SFEBES2007

Outcome of radio-active iodine treatment for thyrotoxicosis in Glan Clwyd Hospital 2003–2005

Swidan Ahmed , Platts Julia , Hassanein Mohammed

Background: There is controversy about the ideal outcome for radio-active iodine (RAI) treatment in thyrotoxicosis and the optimal dose to be given. Various centres use various doses ranging from 185 mBq to 550 mBq.Aim: Our aim was to determine the thyroid status post RAI treatment for thyrotoxicosis and in those who became hypothyroid, to assess the time of onset of hypothyroidism from the date of RAI treatment administration.Meth...

ea0073pep3.8 | Presented ePosters 3: Pituitary and Neuroendocrinology | ECE2021

Temporary oral NaCl tablets safely increase serum sodium in hospitalised elderly patients with hyponatraemia secondary to refractory idiopathic syndrome of inappropriate diuresis (SIAD)

Latorre Julia Calvo , Senanayake Russell , Bashari Waiel A

IntroductionHyponatraemia is the most common electrolyte abnormality encountered within the inpatient setting and is associated with increased morbidity, mortality and length of hospital stay. It compromises a spectrum of symptoms, from being asymptomatic to varying degrees of neurological disturbances including gait abnormalities with increased risk of falls, confusion and rarely seizures. This is of particular relevance in the midst of an aging populat...

ea0073aep286 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Brain perfusion in patients with type 1 diabetes and cognitive dysfunction

Matveeva Mariia , Samoilova Julia , Tonkih Olga

Purpose of the studyEvaluation of cerebral microcirculation using contrast and non-contrast magnetic resonance perfusion in patients with type 1 diabetes and cognitive dysfunction.Material and methodsThe study complied with generally accepted ethical rules. The study included 45 patients with type 1 diabetes mellitus with cognitive dysfunction and 20 patients without. All patients were continuously monitored ...

ea0104p12 | Adrenal & Cardiovascular | SFEIES24

Exploring patient and caregivers’ perceptions and experiences of administering hydrocortisone injection during an adrenal crisis: a mixed-methods cross-sectional study

Llahana Sofia , Anthony Julia , Ross Richard

Background: Patients with AI and their caregivers face significant challenges during adrenal crises, particularly with hydrocortisone injections often requiring up to 20 steps to administer, which impedes effective self-treatment.Aim: To explore the perceptions and experiences of patients with AI and their caregivers regarding the administration of hydrocortisone injections during an adrenal crisis.Methods: Participants were recrui...

ea0049ep1218 | Clinical case reports - Thyroid/Others | ECE2017

Thyroid nodule size at ultrasound as a predictor of malignancy

Gallardo Gema Lopez , Sastre Julia , Gonzalez Abel , Arranz Sandra , Silva Julia , Valero Miguel Angel , Aranda Jaime

Introduction: Most thyroid nodules are benign. Some studies have shown largest nodule size, specially >4 cm, can predict malignancy and reduce fine needle aspiration (FNA) accuracy. Recent studies, however, have shown conflicting results as to whether nodule size may be used to distinguish at risk-lesions. We attempt to determine whether nodule size predicts thyroid malignancy and to examine accuracy of fine needle aspiration (FNA) by size.Material a...

ea0070aep164 | Bone and Calcium | ECE2020

Increasing incidence of parathyroid carcinoma according to russian registry of the primary hyperparathyroidism

Krupinova Julia , Veretennikova Julia , Maganeva Irina , Eremkina Anna , Aynetdinova Alina , Mirnaya Svetlana , Mokrysheva Natalia

Introduction: Parathyroid carcinoma (PC) occurs in 0.005% of all malignant tumors and in less than 1% in primary hyperparathyroidism (PHPT), but recent reports indicate increasing incidence of PC.Aim: To estimate the prevalence of PC in Russia and to identify its distinctive characteristics relevant as preoperative markers.Material and methods: We conducted a retrospective study based on the online Russian Registry of 3061 patients...

ea0070ep106 | Bone and Calcium | ECE2020

Parathyroid cancer: Clinical case

Volkova Natalya , Davidenko Ilya , Dzherieva Irina , Zibarev Alexander , Ganenko Lilia , Reshetnikov Igor , Sorokina Julia , Degtyareva Julia

Background: Parathyroid cancer is a rare pathology, approximately 2 cases per 10, 000, 000 people/year. The five-year survival rate for this disease ranges from 20–85%, and the ten-year survival rate is approximately 15–80%. Timely detection and compliance with algorithms for parathyroid gland cancer diagnostics allows surgical treatment and maximum positive prognosis for patient.Clinical case: Patient 18 y.o., was presented with complaints t...

ea0099p147 | Reproductive and Developmental Endocrinology | ECE2024

Revised adolescent PCOS criteria: implications for women’s metabolic well-being

Nowak-Ciołek Maria , Stachowiak Julia , Krok Katarzyna , Sokal Julia , Malczyk Żaneta , Zachurzok Agnieszka

Introduction: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies in women. In recent years revised diagnostic criteria for PCOS in adolescent females were disseminated. These new criteria notably encompass the specification of irregular menstrual cycles and hyperandrogenism, with the exclusion of polycystic ovarian morphology. In our study, we aimed to verify whether the clinical presentation of adolescent patients meeting the new criteria is associate...

ea00100p15 | Poster Presentations | SFEEU2024

Finding the culprit – a case of multifactorial hypercalcaemia

Calvo Latorre Julia , Sheikh Anum , Agarwal Pallavi , Kostoula Melina , Palazzo Fausto , E Ostberg Julia

Case history: We present the case of a 59-year-old gentleman admitted to our hospital in February 2023 with severe hypercalcaemia. He had a background of mild intermittent hypercalcaemia since 2018 (highest 2.73 mmol/l), chronic kidney disease, hypertension, and a recently climbing prostate-specific antigen that had warranted a 2-week-wait Urology referral. On admission, his only symptom was constipation, without weight loss or constitutional symptoms. His parathyroid hormone ...

ea0077oc2.3 | Endocrine Cancer and Late Effects | SFEBES2021

A novel in vivo platform for studying tumour vascularization and endocrine responses

Lopes Tatiana , Prague Julia , Salem Victoria , Owen Bryn

Background: Tumour growth is critically dependent on blood perfusion, its source of oxygen and nutrients. Therefore, tumour vascularization has become an attractive target for the treatment of many cancers types. The study of endocrine-responsive tumours, in particular, needs improved platforms to screen drugs targeting vascularization that have better resolution and that do not compromise on inter-individual variability.Aim: Hence, we’ve set out to...